Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 40,409 | 35,754 | 30,820 | 20,255 | 22,600 |
| Gross Profit | 40,409 | 35,754 | 30,820 | 20,255 | 22,600 |
| Operating Expenses | 54,439 | 45,932 | 40,320 | 32,243 | 34,396 |
| Operating Income | -14,030 | -10,178 | -9,500 | -11,988 | -11,796 |
| Interest Expense | 7,965 | 155 | 0 | 0 | 0 |
| Other Income | 22,647 | 0 | 0 | -11,887 | 0 |
| Pre-tax Income | 652 | -10,333 | -9,500 | -23,875 | -11,796 |
| Income Tax | 5 | N/A | 0 | 0 | 0 |
| Net Income Continuous | 647 | -10,333 | -9,502 | -11,975 | -11,796 |
| Net Income | $647 | $-10,333 | $-9,500 | $-23,875 | $-11,796 |
| EPS Basic Total Ops | 0.01 | -0.14 | -0.13 | -0.34 | -0.19 |
| EPS Basic Continuous Ops | 0.01 | -0.14 | -0.13 | -0.17 | -0.19 |
| EPS Diluted Total Ops | 0.01 | -0.14 | -0.13 | -0.34 | -0.19 |
| EPS Diluted Continuous Ops | 0.01 | -0.14 | -0.13 | -0.17 | -0.19 |
| EBITDA(a) | $-9,832 | $-6,640 | $-5,810 | $-8,744 | $-8,554 |